Authors:
WALLACE P
SIGNER E
PATON IR
BURT D
QUINLAN R
Citation: P. Wallace et al., THE CHICKEN CP49 GENE CONTAINS AN EXTRA EXON COMPARED TO THE HUMAN CP49 GENE WHICH IDENTIFIES AN IMPORTANT STEP IN THE EVOLUTION OF THE EYELENS INTERMEDIATE FILAMENT PROTEINS, Gene, 211(1), 1998, pp. 19-27
Authors:
PASSWEG JR
GRATWOHL A
TICHELLI A
HOFFMANN T
NISSEN C
KUHNE T
FAVRE G
AVOLEDO P
CORNU P
HERRMANN R
JEANNET M
OSTERWALDER B
SARTORIUS J
SCHIFFERLI JA
SIGNER E
STAUFFACHER T
SPECK B
Citation: Jr. Passweg et al., 25 YEARS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN BASEL - 1973-1398, Schweizerische medizinische Wochenschrift, 128(42), 1998, pp. 1568-1574
Authors:
TICHELLI A
PASSWEG J
NISSEN C
BARGETZI M
HOFFMANN T
WODNARFILIPOWICZ A
SIGNER E
SPECK B
GRATWOHL A
Citation: A. Tichelli et al., REPEATED TREATMENT WITH HORSE ANTILYMPHOCYTE GLOBULIN FOR SEVERE APLASTIC-ANEMIA, British Journal of Haematology, 100(2), 1998, pp. 393-400
Authors:
BARGETZI MJ
SCHONENBERGER A
TICHELLI A
FRIED R
CATHOMAS G
SIGNER E
SPECK B
GRATWOHL A
Citation: Mj. Bargetzi et al., CELIAC-DISEASE TRANSMITTED BY ALLOGENEIC NON-T CELL-DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(7), 1997, pp. 607-609
Authors:
TICHELLI A
GRATWOHL A
BARGETZI M
NISSEN C
WERNLI M
HERRMANN R
ORTH B
SIGNER E
SPECK B
Citation: A. Tichelli et al., AUTOLOGOUS PERIPHERAL-BLOOD PRECURSOR CEL L TRANSPLANTATION AFTER CD34 SELECTION, Schweizerische medizinische Wochenschrift, 126(6), 1996, pp. 201-206
Authors:
SPECK B
TICHELLI A
WIDMER E
HARDER F
KISSLING M
WURSCH A
GYSI CS
SIGNER E
BARGETZI M
ORTH B
GRATWOHL A
NISSEN C
Citation: B. Speck et al., SPLENECTOMY AS AN ADJUVANT MEASURE IN THE TREATMENT OF SEVERE APLASTIC-ANEMIA, British Journal of Haematology, 92(4), 1996, pp. 818-824
Authors:
IMBACH P
FUCHS A
BERCHTOLD W
ARNET B
STUPNICKI A
ANGST R
SIGNER E
Citation: P. Imbach et al., BOYS BUT NOT GIRLS WITH T-LINEAGE ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) ARE DIFFERENT FROM CHILDREN WITH B-PROGENITOR ALL - POPULATION-BASED DATA RESULTS OF INITIAL PROGNOSTIC FACTORS AND LONG-TERM EVENT-FREE SURVIVAL, Journal of pediatric hematology/oncology, 17(4), 1995, pp. 346-349
Authors:
ARCHIBALD AL
HALEY CS
BROWN JF
COUPERWHITE S
MCQUEEN HA
NICHOLSON D
COPPIETERS W
VANDEWEGHE A
STRATIL A
WINTERO AK
FREDHOLM M
LARSEN NJ
NIELSEN VH
MILAN D
WOLOSZYN N
ROBIC A
DALENS M
RIQUET J
GELLIN J
CARITEZ JC
BURGAUD G
OLLIVIER L
BIDANEL JP
VAIMAN M
RENARD C
GELDERMANN H
DAVOLI R
RUYTER D
VERSTEGE EJM
GROENEN MAM
DAVIES W
HOYHEIM B
KEISERUD A
ANDERSSON L
ELLEGREN H
JOHANSSON M
MARKLUND L
MILLER JR
DEAR DVA
SIGNER E
JEFFREYS AJ
MORAN C
LETISSIER P",MULADNO,"ROTHSCHILD MF
TUGGLE CK
VASKE D
HELM J
LIU HC
RAHMAN A
YU TP
LARSON RG
SCHMITZ CB
Citation: Al. Archibald et al., THE PIGMAP CONSORTIUM LINKAGE MAP OF THE PIG (SUS SCROFA), Mammalian genome, 6(3), 1995, pp. 157-175
Authors:
STUPNICKI A
VONDERWEID N
IMBACH P
ARNET B
BERCHTOLD W
DELALEU B
HIRT A
PLUESS HJ
BECK D
WYSS M
LUETHY AR
FELDGES A
SIGNER E
MORIN AM
CAFLISCH U
LEIBUNDGUT K
FREY E
KUECHLER H
BAUMGARTNER C
BLEHER EA
ANGST R
BLAUENSTEIN U
NOBILE L
VISCHER D
WAGNER HP
Citation: A. Stupnicki et al., INCIDENCE OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND POPULATION-BASED TREATMENT RESULTS IN SWITZERLAND - EXPERIENCES WITH 507 STUDY AND 149 NONSTUDY PATIENTS, Medical and pediatric oncology, 25(2), 1995, pp. 79-83
Authors:
WAGNER HP
DINGELDEINBETTLER I
BERCHTHOLD W
LUTHY AR
HIRT A
PLUSS HJ
BECK D
WYSS M
SIGNER E
IMBACH P
FELDGES A
BLEHER EA
PLASCHKES J
BRINER J
LEIBUNDGUT K
VONDERWEID N
Citation: Hp. Wagner et al., CHILDHOOD NHL IN SWITZERLAND - INCIDENCE AND SURVIVAL OF 120 STUDY AND 42 NON-STUDY PATIENTS, Medical and pediatric oncology, 24(5), 1995, pp. 281-286
Authors:
TICHELLI A
KRALJ A
HUXOL H
SCHONENBERGER A
RABAGLIO M
BOREL J
MULLER R
BARGETZI M
GRATWOHL A
SIGNER E
SPECK B
Citation: A. Tichelli et al., FLOW-CYTOMETRIC QUANTIFICATION OF CD34-PO SITIVE CELLS, Schweizerische medizinische Wochenschrift, 125(9), 1995, pp. 400-404
Authors:
GHIA P
GRATWOHL A
SIGNER E
WINKLER TH
MELCHERS F
ROLINK AG
Citation: P. Ghia et al., IMMATURE B-CELLS FROM HUMAN AND MOUSE BONE-MARROW CAN CHANGE THEIR SURFACE LIGHT-CHAIN EXPRESSION, European Journal of Immunology, 25(11), 1995, pp. 3108-3114
Authors:
VONDERWEID N
WAGNER B
ANGST R
ARNET B
BAUMGARTNER C
BECK D
BLEHER A
CAFLISCH U
DELALEU B
FELDGES A
FREY E
GLANZMANN I
HIRT A
IMBACH P
KRATEL S
KUCHLER H
LEIBUNDGUT K
MEISTER A
MORIN AM
NOBILE L
PLUSS HJ
LUTHY AR
SIGNER E
STETTLER E
WYSS M
WAGNER HP
Citation: N. Vonderweid et al., TREATMENT OF RELAPSING ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD .3. EXPERIENCES WITH 54 FIRST BONE-MARROW, 9 ISOLATED TESTICULAR, AND 8 ISOLATED CENTRAL-NERVOUS-SYSTEM RELAPSES OBSERVED 1985-1989, Medical and pediatric oncology, 22(6), 1994, pp. 361-369
Authors:
GRATWOHL A
TICHELLI A
STAUFFER G
PASSWEG J
PLESS M
GENGENBACHER D
BUSER U
SIGNER E
HABERTHUR C
GIMMI C
WERNLI M
GYSI CS
NISSEN C
SPECK B
Citation: A. Gratwohl et al., LENGTH OF CYCLOSPORINE THERAPY AFTER BONE -MARROW TRANSPLANT, Schweizerische medizinische Wochenschrift, 124(1-2), 1994, pp. 44-50
Citation: T. Kuhne et al., ALL-TRANS-RETINOIC ACID AS AN ALTERNATIVE TO CHEMOTHERAPY IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, Pediatric hematology and oncology, 10(4), 1993, pp. 363-367